4.6 Article

Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?

Related references

Note: Only part of the references are listed.
Review Oncology

Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review

Sajad Fakhri et al.

Summary: Signaling pathways and metabolites control metabolism in normal and cancer cells. Abnormal activities of these pathways are noticeable events in cancer and targeting them has become a hot topic in cancer research. Natural secondary metabolites have shown promising anticancer effects by targeting dysregulated signaling pathways linked to cancer metabolism.

SEMINARS IN CANCER BIOLOGY (2022)

Article Oncology

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments

Shogo Kumagai et al.

Summary: In highly glycolytic tumors, regulatory T (Treg) cells have higher PD-1 expression compared to effector T cells. Under low-glucose conditions, Treg cells actively absorb lactic acid through monocarboxylate transporter 1 (MCT1), promoting the expression of PD-1, while PD-1 expression by effector T cells is dampened. PD-1 blockade invigorates PD-1-expressing Treg cells, resulting in treatment failure.

CANCER CELL (2022)

Article Oncology

Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer

Adele M. Nicolas et al.

Summary: The study reveals that inflammatory cancer-associated fibroblasts (iCAFs) in rectal cancer patients are associated with poor response to chemoradiotherapy. The researchers found that interleukin-1 alpha (IL-1 alpha) not only polarizes iCAFs towards an inflammatory phenotype but also triggers oxidative DNA damage, leading to p53-mediated therapy-induced senescence. This senescence of iCAFs results in chemoradiotherapy resistance and disease progression. Inhibition of IL-1 signaling or prevention of iCAFs senescence could sensitize mice to irradiation and improve therapy response.

CANCER CELL (2022)

Review Cell Biology

The hallmarks of cancer metabolism: Still emerging

Natalya N. Pavlova et al.

Summary: The metabolism of cancer cells is highly adaptable, allowing them to sustain growth and proliferation. This adaptation can also influence the behavior of non-transformed cells in the tumor vicinity.

CELL METABOLISM (2022)

Review Biochemistry & Molecular Biology

In Vivo Anticancer Activity of AZD3965: A Systematic Review

Ana Silva et al.

Summary: The transportation of lactate produced by glycolytic cancer cells plays a crucial role in cancer development, with MCT1 being a key transporter. The specific MCT1 inhibitor AZD3965 has shown promising anticancer effects in vivo, especially in combination therapy. This suggests its potential as a valuable treatment option in clinical settings.

MOLECULES (2022)

Article Neurosciences

Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease

Jingyi Li et al.

Summary: In this study, the researchers investigated the changes in lactate metabolism in a Parkinson's disease model and found that the expression of HK2 and LDHA as well as lactate levels were significantly increased. They also found that lactate treatment induces apoptosis in neuronal cells, while the inhibition of HK2 suppresses lactate production and dopaminergic neuron apoptosis. Moreover, the HK2 inhibitor improves motor behavior in the Parkinson's disease model mice. Mechanistically, lactate increases AMPK activity and inhibits phosphorylation of Akt and mTOR.

NEUROBIOLOGY OF DISEASE (2022)

Review Oncology

Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures

Bing Feng et al.

Summary: Cancer-associated fibroblasts (CAFs) play critical roles in the tumor microenvironment, including extracellular matrix remodeling, metabolic modulation, and angiogenesis. They interact with cancer cells and immune cells through the production of growth factors, cytokines, and chemokines. CAFs have the potential to modulate the sensitivity of anti-cancer therapies, making them potential targets for optimizing cancer treatments.

CANCER CELL INTERNATIONAL (2022)

Editorial Material Cell Biology

Editorial: Metabolite and Nutrient Transporters in Cancer-Cell Metabolism: Role in Cancer Progression and Metastasis

Vadivel Ganapathy et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Oncology

Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics

Dolly Sharma et al.

Summary: Lactate dehydrogenase plays a crucial role in tumor metabolism, and its inhibition may be a potential approach for anticancer therapy.

SEMINARS IN CANCER BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification

Chloe Buyse et al.

Summary: Extracellular acidification promotes invasion and migration of invasive tumors, but targeting transporters involved in tumor pH regulation can disrupt tumor cell metabolism and proliferation. However, the inhibitor syrosingopine did not show significant changes in extracellular pH and primary tumor growth in in vivo experiments.

METABOLITES (2022)

Review Biochemistry & Molecular Biology

Metabolic Reprogramming in Tumor Endothelial Cells

Melissa Garcia-Caballero et al.

Summary: The dynamic crosstalk between different components of the tumor microenvironment plays a critical role in cancer progression and metastasis. Angiogenesis is crucial for tumor growth, but abnormal blood vessels can lead to hypoxia and acidosis in the tumor microenvironment. Cancer and stromal cells can alter their metabolism to meet high energy demands and promote tumor proliferation. Recent studies have shown that the metabolism of tumor endothelial cells is reprogrammed and targeting these metabolic pathways can affect blood vessel formation. Therefore, metabolic antiangiogenic therapies combined with immunotherapies offer a clinical opportunity for cancer treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

Lactate increases stemness of CD8+T cells to augment anti-tumor immunity

Qiang Feng et al.

Summary: Lactate increases stemness of CD8(+) T cells and enhances anti-tumor immunity. It inhibits histone deacetylase activity, leading to increased expression of Tcf7 gene, and affects the stemness of T cells.

NATURE COMMUNICATIONS (2022)

Review Biochemistry & Molecular Biology

Lactate metabolism in human health and disease

Xiaolu Li et al.

Summary: This article provides a comprehensive review of the role of lactate, clarifying its involvement in diseases and offering references and direction for future research.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Engineering, Biomedical

Tumor-Targeted Inhibition of Monocarboxylate Transporter 1 Improves T-Cell Immunotherapy of Solid Tumors

Tongyi Huang et al.

Summary: A pH-activatable nanodrug for tumor-targeted inhibition of MCT1 has been developed to reverse lactic acid-induced tumor immunosuppression. In animal studies, this nanodrug demonstrated potent tumor growth inhibition and increased survival, with reduced drug distribution in heart and liver tissues.

ADVANCED HEALTHCARE MATERIALS (2021)

Review Oncology

The Chemosensitizing Role of Metformin in Anti-Cancer Therapy

Zhimin Tang et al.

Summary: Metformin, a widely used antidiabetic drug, has shown anti-cancer effects by sensitizing tumors to various chemotherapeutic drugs. It targets Cancer Stem Cells, improves the hypoxic microenvironment, and suppresses tumor metastasis and inflammation, leading to enhanced sensitivity of cancer cells to chemotherapy.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

SLC16 Family: From Atomic Structure to Human Disease

Patrick D. Bosshart et al.

Summary: The SLC16 family consists of diverse membrane proteins mediating the transport of monocarboxylates across biological membranes, playing roles in nutrient transport, intracellular pH regulation, and thyroid hormone homeostasis. Alterations in expression levels and transport function of specific SLC16 transporters are associated with severe health disorders, while members transporting L-lactate play crucial roles in tumor metabolism. Structural information from a SLC16 homolog sheds new light on the family, discussing their role in cancer metabolism and potential for anticancer therapy through their inhibition.

TRENDS IN BIOCHEMICAL SCIENCES (2021)

Article Cell Biology

The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure

Ahmad A. Cluntun et al.

Summary: The metabolic rewiring of cardiomyocytes, including decreased mitochondrial pyruvate oxidation and increased lactate export, is a key feature of heart failure. The mitochondrial pyruvate carrier (MPC) and the cellular lactate exporter monocarboxylate transporter 4 (MCT4) play pivotal roles in this metabolic axis. Alteration of the pyruvate-lactate axis is a fundamental and early feature of cardiac hypertrophy and failure.

CELL METABOLISM (2021)

Review Oncology

Targeting hypoxic tumor microenvironment in pancreatic cancer

Jinxin Tao et al.

Summary: Pancreatic cancer, characterized by late diagnosis, early metastasis, and poor prognosis, exhibits high lethality globally. The hypoxic microenvironment in pancreatic cancer has extensive effects on biological behaviors and malignant phenotypes, leading to aggressive progression and therapeutic resistance. Innovative therapies targeting the tumor hypoxic microenvironment show great potential in overcoming treatment resistance and enhancing antitumor efficacy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

Non-coding RNAs rewire cancer metabolism networks

Xiaorong Lin et al.

Summary: Non-coding RNAs are functional RNAs that play a role in regulating disease development, particularly in cancer metabolic reprogramming. They can influence cancer metabolism regulation by directly modulating metabolic enzyme activities or participating in metabolism-related signaling pathways.

SEMINARS IN CANCER BIOLOGY (2021)

Article Oncology

Overexpression of monocarboxylate transporter 4 promotes the migration and invasion of non-carcinogenic L929 fibroblast cells

Xiangru Li et al.

Summary: Metastasis is a major contributing factor to low cancer patient survival rates, and overexpression of MCT4 promotes cancer cell migration and invasion by modulating the EGF/EGFR pathway.

ONCOLOGY LETTERS (2021)

Article Oncology

Targeting of Evolutionarily Acquired Cancer Cell Phenotype by Exploiting pHi-Metabolic Vulnerabilities

Bryce Ordway et al.

Summary: Utilizing selective biological forces to manipulate intracellular and extracellular pH levels can control tumor progression and guide it towards a less invasive trajectory. This approach can lead to the inhibition of aggressive cancer cell populations in favor of slower growth and less damage to patients, ultimately controlling cancer in cases where a cure is not an option.

CANCERS (2021)

Article Multidisciplinary Sciences

Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome

Martin Leu et al.

Summary: The study evaluated the potential of MCT1 and MCT4 as biomarkers in HNSCC patients, finding that positive staining for MCT1 was strongly associated with worsened PFS and OS, indicating it could be a promising biomarker in HNSCC treated by primary RCT.

SCIENTIFIC REPORTS (2021)

Article Oncology

Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy

Robert D. Leone et al.

Summary: The success of immune-based therapies for cancer has highlighted the critical role of metabolic programs specific to immune cell type and function. Understanding the metabolic requirements of immune cells in the tumor microenvironment can significantly improve the efficacy of cancer immunotherapy.

CANCER IMMUNOLOGY RESEARCH (2021)

Article Biochemistry & Molecular Biology

Cysteine 159 delineates a hinge region of the alternating access monocarboxylate transporter 1 and is targeted by cysteine-modifying inhibitors

Anna-Lena Kopnick et al.

Summary: Monocarboxylate transporter isoforms play a crucial role in proton-coupled transport of l-lactate, potentially offering promising targets for anticancer therapy. This study identified Cys159 as a critical binding site for the inhibitory effects of pCMBS on MCT1 and provided insights into the mechanism of action.

FEBS JOURNAL (2021)

Article Medicine, General & Internal

Lactate in the tumour microenvironment: From immune modulation to therapy

Zi-Hao Wang et al.

Summary: This review focuses on recent advances in the regulation of immune responses by lactate in the tumour microenvironment, as well as therapeutic strategies targeting lactate anabolism and transport. Lactate plays multifaceted roles in influencing immune responses, and a comprehensive understanding of how lactate and lactate-targeting therapies regulate immune responses in the TME may provide insights into the complex relationships between metabolism and antitumour immunity.

EBIOMEDICINE (2021)

Review Nutrition & Dietetics

Role of the Heart in Lactate Shuttling

George A. Brooks

Summary: After years of misunderstanding, it is now recognized that lactate shuttling plays a crucial role in energy flux and metabolic regulation in vivo, especially during physical exercise. The complex series of events involved in lactate shuttling highlight its importance in energy substrate production and distribution, as well as cell signaling.

FRONTIERS IN NUTRITION (2021)

Article Chemistry, Medicinal

Discovery of 5-{2-[5-Chloro-2-(5-ethoxyquinoline-8-sulfonamido)phenyl]ethynyl}-4-methoxypyridine-2-carboxylic Acid, a Highly Selective in Vivo Useable Chemical Probe to Dissect MCT4 Biology

Timo Heinrich et al.

Summary: This study describes the discovery and optimization of a novel class of MCT4 inhibitors that inhibit lactate efflux and reduce cellular viability in MCT4 high expressing cells. The optimized compound 18n showed direct target interaction with MCT4 and allowed assessment of lactate modulation and antitumor activity in a mouse tumor model. Compound 18n represents a valuable tool for investigating selective MCT4 inhibition and its effect on tumor biology.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Cell Biology

Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition

Catherine Vander Linden et al.

Summary: Metabolic plasticity in cancer cells presents challenges in using metabolism-targeting agents, but drug-induced metabolic rewiring can uncover vulnerabilities that may be exploited for treatment efficacy.

CELL REPORTS (2021)

Article Oncology

PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1

Alice Matheux et al.

Summary: The study indicates that the expression of PXR in castration-resistant prostate cancer cells can impact the response to kinase inhibitors, thus affecting treatment outcomes. The modulation of specific kinase inhibitors' effects on prostate cancer cells by PXR highlights the potential importance of considering PXR as a biomarker for response to treatment in clinical settings.

CANCERS (2021)

Article Oncology

MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma

Vera Miranda-Goncalves et al.

Summary: The overexpression of MCT1 is associated with poor prognosis in GBM patients. Inhibiting MCT1 can slow down tumor growth and enhance response to temozolomide treatment in GBM.

CANCERS (2021)

Review Endocrinology & Metabolism

Monocarboxylate transporters in cancer

Valery L. Payen et al.

MOLECULAR METABOLISM (2020)

Article Biochemistry & Molecular Biology

Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway

Yana Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Urology & Nephrology

Competitive glucose metabolism as a target to boost bladder cancer immunotherapy

Julieta Afonso et al.

NATURE REVIEWS UROLOGY (2020)

Article Biotechnology & Applied Microbiology

Quercetin Enhanced Paclitaxel Therapeutic Effects Towards PC-3 Prostate Cancer Through ER Stress Induction and ROS Production

Xiangyu Zhang et al.

ONCOTARGETS AND THERAPY (2020)

Review Oncology

Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy

Fatima Baltazar et al.

FRONTIERS IN ONCOLOGY (2020)

Review Oncology

Oxidative Stress in Cancer

John D. Hayes et al.

CANCER CELL (2020)

Review Oncology

Mechanisms of Cancer Resistance to Immunotherapy

Rilan Bai et al.

FRONTIERS IN ONCOLOGY (2020)

Review Cell Biology

Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential

Xiangyu Sun et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Neurosciences

Lactate Transporters Mediate Glia-Neuron Metabolic Crosstalk in Homeostasis and Disease

Mithilesh Kumar Jha et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Article Medicine, Research & Experimental

Radio-sensitizing effect of a cocktail of phytochemicals on HepG2 cell proliferation, motility and survival

Mohamed E. Abdraboh et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Oncology

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai et al.

NATURE REVIEWS CANCER (2020)

Article Biochemistry & Molecular Biology

Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways

Xinxing Lu et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Review Biochemistry & Molecular Biology

Lactate: A Metabolic Driver in the Tumour Landscape

Luigi Ippolito et al.

TRENDS IN BIOCHEMICAL SCIENCES (2019)

Review Biochemistry & Molecular Biology

Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology

Amit J. Sabnis et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Review Oncology

The roles of glucose metabolic reprogramming in chemo- and radio-resistance

Jinguan Lin et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Multidisciplinary Sciences

Mechanistic basis of L-lactate transport in the SLC16 solute carrier family

Patrick D. Bosshart et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments

Yasna Contreras-Baeza et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Food Science & Technology

Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells

Chieh-Yu Lan et al.

JOURNAL OF FOOD AND DRUG ANALYSIS (2019)

Review Oncology

Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches

Karen G. de la Cruz-Lopez et al.

FRONTIERS IN ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling

Alberto Cruz-Bermudez et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

Article Biochemistry & Molecular Biology

Membrane-anchored carbonic anhydrase IV interacts with monocarboxylate transporters via their chaperones CD147 and GP70

Linda S. Forero-Quintero et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Identification of a selective inhibitor of human monocarboxylate transporter 4

Yuya Futagi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Review Cell Biology

The Science and Translation of Lactate Shuttle Theory

George A. Brooks

CELL METABOLISM (2018)

Review Medicine, Research & Experimental

Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy

Pascale Fisel et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)

Review Physiology

ENDOTHELIAL CELL METABOLISM

Guy Eelen et al.

PHYSIOLOGICAL REVIEWS (2018)

Review Biochemistry & Molecular Biology

Metabolic Control of CD8+ T Cell Fate Decisions and Antitumor Immunity

Lianjun Zhang et al.

TRENDS IN MOLECULAR MEDICINE (2018)

Review Immunology

Metabolic Reprogramming and Longevity of Tissue-Resident Memory T Cells

Youdong Pan et al.

FRONTIERS IN IMMUNOLOGY (2018)

Editorial Material Chemistry, Medicinal

When will small molecule lactate dehydrogenase inhibitors realize their potential in the cancer clinic?

Reshma Rani et al.

FUTURE MEDICINAL CHEMISTRY (2017)

Article Medicine, Research & Experimental

Quercetin, Morin, Luteolin, and Phloretin Are Dietary Flavonoid Inhibitors of Monocarboxylate Transporter 6

Robert S. Jones et al.

MOLECULAR PHARMACEUTICS (2017)

Review Urology & Nephrology

Metabolic reprogramming in clear cell renal cell carcinoma

Hiromi I. Wettersten et al.

NATURE REVIEWS NEPHROLOGY (2017)

Review Oncology

Value of pH regulators in the diagnosis, prognosis and treatment of cancer

Sara Granja et al.

SEMINARS IN CANCER BIOLOGY (2017)

Review Immunology

Strategies to improve the efficacy of Dendritic Cell-Based immunotherapy for Melanoma

Kristian M. Hargadon

FRONTIERS IN IMMUNOLOGY (2017)

Review Biochemistry & Molecular Biology

Endothelial cell metabolism in health and disease: impact of hypoxia

Brian W. Wong et al.

EMBO JOURNAL (2017)

Article Biochemistry & Molecular Biology

MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer

Chunlin Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Cell Biology

MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer

Jennifer M. Johnson et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)

Review Genetics & Heredity

Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H+ symporters

Ibtissam Marchiq et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2016)

Article Biochemistry & Molecular Biology

Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine

Yangzom D. Bhutia et al.

BIOCHEMICAL JOURNAL (2016)

Article Cell Biology

In Vivo Evidence for a Lactate Gradient from Astrocytes to Neurons

Philipp Machler et al.

CELL METABOLISM (2016)

Article Physiology

Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells

Tetsuya Takada et al.

JOURNAL OF PHYSIOLOGICAL SCIENCES (2016)

Article Multidisciplinary Sciences

Syrosingopine sensitizes cancer cells to killing by metformin

Don Benjamin et al.

SCIENCE ADVANCES (2016)

Article Biochemistry & Molecular Biology

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

Chih-Hao Chang et al.

Article Sport Sciences

VARIANTS OF THE SOLUTE CARRIER SLC16A1 GENE (MCT1) ASSOCIATED WITH METABOLIC RESPONSES DURING A LONG-GRADED TEST IN ROAD CYCLISTS

Carlos Gonzalez-Haro et al.

JOURNAL OF STRENGTH AND CONDITIONING RESEARCH (2015)

Article Chemistry, Medicinal

Monocarboxylate Transporter 1 Inhibitors as Potential Anticancer Agents

Shirisha Gurrapu et al.

ACS MEDICINAL CHEMISTRY LETTERS (2015)

Review Immunology

Glucose metabolism regulatesT cell activation, differentiation, and functions

Clovis S. Palmer et al.

FRONTIERS IN IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance

Julieta Afonso et al.

MOLECULAR CARCINOGENESIS (2015)

Article Oncology

Cell Surface Lactate Receptor GPR81 Is Crucial for Cancer Cell Survival

Christina L. Roland et al.

CANCER RESEARCH (2014)

Article Oncology

Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer

Radoslaw Polanski et al.

CLINICAL CANCER RESEARCH (2014)

Article Biochemistry & Molecular Biology

S-nitrosation of monocarboxylate transporter 1: Inhibition of pyruvate-fueled respiration and proliferation of breast cancer cells

Anne R. Diers et al.

FREE RADICAL BIOLOGY AND MEDICINE (2014)

Article Medicine, General & Internal

Monocarboxylate Transporter 1 Deficiency and Ketone Utilization

Peter M. van Hasselt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Biochemistry & Molecular Biology

Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells

Nihed Draoui et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2013)

Article Medicine, Research & Experimental

Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function

Madhusudhanan Sukumar et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Biochemistry & Molecular Biology

The SLC16 gene family - Structure, role and regulation in health and disease

Andrew P. Halestrap

MOLECULAR ASPECTS OF MEDICINE (2013)

Review Biochemistry & Molecular Biology

Cancer cell metabolism: implications for therapeutic targets

Miran Jang et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2013)

Review Biochemistry & Molecular Biology

The monocarboxylate transporter familyuRole and regulation

Andrew P. Halestrap et al.

IUBMB LIFE (2012)

Review Biophysics

Role of monocarboxylate transporters in human cancers: state of the art

Celine Pinheiro et al.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)

Article Multidisciplinary Sciences

Oligodendroglia metabolically support axons and contribute to neurodegeneration

Youngjin Lee et al.

NATURE (2012)

Article Biochemistry & Molecular Biology

miR-29a and miR-29b Contribute to Pancreatic β-Cell-Specific Silencing of Monocarboxylate Transporter 1 (Mct1)

Timothy J. Pullen et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

Article Multidisciplinary Sciences

Intramolecular proton shuttle supports not only catalytic but also noncatalytic function of carbonic anhydrase II

Holger M. Becker et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Multidisciplinary Sciences

CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors

Renaud Le Floch et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein

Matthew J. Ovens et al.

BIOCHEMICAL JOURNAL (2010)

Article Cell Biology

Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma

Celine Pinheiro et al.

HISTOPATHOLOGY (2010)

Article Biotechnology & Applied Microbiology

Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44

Celine Pinheiro et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)

Article Sport Sciences

MCT1 genetic polymorphism influence in high intensity circuit training: A pilot study

Rocio Cupeiro et al.

JOURNAL OF SCIENCE AND MEDICINE IN SPORT (2010)

Article Biochemistry & Molecular Biology

Quiescent Fibroblasts Exhibit High Metabolic Activity

Johanna M. S. Lemons et al.

PLOS BIOLOGY (2010)

Article Cell Biology

Interaction of monocarboxylate transporter 4 with β1-integrin and its role in cell migration

Shannon M. Gallagher et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)

Review Oncology

Regulation of cancer cell metabolism by hypoxia-inducible factor 1

Gregg L. Semenza

SEMINARS IN CANCER BIOLOGY (2009)

Review Pharmacology & Pharmacy

Sodium-coupled monocarboxylate transporters in normal tissues and in cancer

Vadivel Ganapathy et al.

AAPS JOURNAL (2008)

Article Obstetrics & Gynecology

Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma

Celine Pinheiro et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)

Article Biochemistry & Molecular Biology

Fibroblasts and myofibroblasts: Their source, function and role in disease

Robin J. McAnulty

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)

Article Biochemistry & Molecular Biology

The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism

MS Ullah et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Monocarboxylate transporter MCT1 is a target for immunosuppression

CM Murray et al.

NATURE CHEMICAL BIOLOGY (2005)

Article Physiology

The expression of lactate transporters (MCT1 and MCT4) in heart and muscle

A Bonen

EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2001)